Basics Forte Biosciences, Inc. IPO Date: April 10, 2017 Sector: Healthcare Industry: Biotech Market Cap: $179.78M Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 4.09% Avg Daily Range (30 D): $0.66 | 5.04% Avg Daily Range (90 D): $0.53 | 4.31% Institutional Daily Volume Avg Daily Volume: .21M Avg Daily Volume (30 D): .07M Avg Daily Volume (90 D): .06M Trade Size Avg Trade Size (Sh.): 153 Avg Trade Size (Sh.) (30 D): 66 Avg Trade Size (Sh.) (90 D): 76 Institutional Trades Total Inst.Trades: 88 Avg Inst. Trade: $1.69M Avg Inst. Trade (30 D): $1.07M Avg Inst. Trade (90 D): $1.1M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.43M Avg Closing Trade (30 D): $1.41M Avg Closing Trade (90 D): $1.41M Avg Closing Volume: 19.16K     News Aug 14, 2025 @ 5:00 PM Vitiligo Clinical Trial Pipeline Accelerates as 18... Source: Delveinsight Jul 4, 2025 @ 10:00 AM Forte and Sequence Partner to Power Web3 Monetizat... Source: Bela Pandya (Forte Ceo) Mar 25, 2024 @ 4:00 PM What Makes Forte Biosciences (FBRX) a New Buy Stoc... Source: Zacks Equity Research Dec 13, 2023 @ 1:29 PM Research Frontiers And 3 Other Stocks Under $1 Ins... Source: Avi Kapoor Dec 11, 2023 @ 1:34 PM RiskOn International And 3 Other Stocks Under $2 I... Source: Avi Kapoor Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.68 $-.96 $-1.37 Diluted EPS $-3.68 $-.96 $-1.37 Revenue $ 1.31M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -42.45M $ -11.25M $ -15.66M Operating Income / Loss $ -43.68M $ -11.58M $ -16.12M Cost of Revenue $ $ $ Net Cash Flow $ 81.65M $ 60.29M $ 23.61M PE Ratio     Splits Aug 28, 2024:   1:25